4SC gains on IBD data

4SC AG (Xetra:VSC) gained EUR 0.41 (15%) to EUR 3.18 on Thursday after reporting that once-daily oral vidofludimus for 12 weeks met the primary endpoint of significantly increasing response rate compa...